Intended Use

Software intended for analysis of non-cardiac-gated non-contrast CT images including the heart in adults aged 30+. Assists physicians by providing four-category Coronary Artery Calcification (CAC) plaque risk assessment with preview axial images for informational purposes only. Results not for standalone clinical decision-making; clinicians responsible for full image review.

Technology

BriefCase-Quantification is a standalone software as a medical device running on a Linux-based cloud server. It processes filtered routine, non-contrast, non-gated CT scans to evaluate calcified plaques in coronary arteries using AI, producing a four-category calcium score output consistent with validated visual assessment and clinical guidelines. Results are integrated into PACS or desktop review software for physician assessment.

Performance

A retrospective, blinded multicenter study on 433 distinct cases showed BriefCase-Quantification achieved 87.1% overall agreement with ground truth in classifying coronary artery calcification categories, meeting prespecified performance goals. Category-level agreement ranged from 81.3% to 95.1%. Performance is equivalent to predicate and reference devices.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    6/5/2023

    5 months
  • 2

    FDA Approval

    11/28/2023

Other devices from Aidoc Medical, Ltd.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.